Reversible, parallel and multitask cloning method and kit

Patent metadata

Field	Value
Publication number	US-9309518-B2
Application number	US-201213660907-A
Country	US
Kind code	B2
Filing date	Oct 25, 2012
Priority date	Sep 3, 2002
Publication date	Apr 12, 2016
Grant date	Apr 12, 2016

Abstract

The present invention is related to integrated method and tools to construct recombinant DNA molecules (to be used as DNA vaccine or gene therapy) without requiring the use of antibiotic(s) resistance gene(s) and without requiring the addition of one or more antibiotic(s) to the culture medium of cells submitted to this recombinant DNA method. The present invention allows to obtain the selection of recombinant host cell(s) transformed by a (exogenous) nucleic acid sequence of interest (extra-chromosomal vector containing the insert) and simultaneously stabilization (stable inheritance) of this (exogenous) nucleic acid sequence of interest into the transformed host cell(s) descendants (maintenance of the nucleic acid sequence of interest in the host cells population).

First claim

What is claimed is:

1. A method for sub-cloning and stabilizing a nucleic acid sequence of interest into a cell this method comprising the steps of:
a) preparing DNA of a receiving vector comprising:
a first nucleotide sequence encoding a first poison protein;
a first pair of two different recombination or restriction sites or recombination arms disposed upstream and downstream the said first nucleotide sequence; and
a second nucleotide sequence encoding an antidote protein to a second poison protein that is different from the said first poison protein, wherein the first and second poison proteins are selected from the group consisting of CcdB, Kid, Doc, RelE, PasA, MazE, and ParE and the antidote protein is selected from the group consisting of CcdA, Kis, Phd, RelB, PasB, PasC, MazF, and ParD;

b) performing recombination between the said receiving vector and a donor vector, said donor vector comprising the nucleic acid sequence of interest being located between a second pair of two different recombination or restriction sites or recombination arms wherein, this second pair of recombination or restriction sites or recombination arms being compatible with the first pair of two recombination sites or recombination arms of the receiving vector;
c) obtaining a chimeric nucleic acid molecule comprising the nucleic acid sequence of interest;
d) transforming the obtained recombination mixture in cell(s) carrying a nucleotide sequence encoding the second poison protein;
e) obtaining a synthesis of the first poison protein and second poison protein and of the antidote protein to the said second poison protein in the cells;
f) selecting cells surviving to the toxic activity of the first poison protein and the second poison protein; and
g) growing and collecting recovered surviving cells comprising the nucleic acid sequence of interest, under selective pressure of the second poison protein.

2. The method according to the claim 1 , wherein the second nucleotide sequence is a sequence encoding the CcdA antidote protein to the CcdB poison protein.

3. The method according to the claim 1 , wherein the first nucleotide sequence is the sequence encoding the Kid poison protein.

4. The method according to claim 1 , wherein the two different recombination sites or arms do not recombine with each other.

5. The method according to claim 1 , wherein the step of inserting the nucleic acid of interest is obtained by incubating a mixture mode of the receiving vector and the donor vector, under conditions sufficient to cause recombination between the recombination sites or recombination arms of the first pair and the second pair, thereby producing the chimeric nucleic acid molecule comprising the nucleic acid sequence of interest.

6. The method of claim 1 , wherein the step of obtaining the cell is a selection of a cell comprising the chimeric nucleic acid molecule and a selection against a cell comprising the receiving vector or against a cell comprising the donor vector or co-integrate of the donor vector and the receiving vector.

7. The method according to claim 1 , wherein the selection of the cell containing chimeric nucleic acid molecule is performed without the addition of antibiotics to the culture medium.

8. The method according to claim 1 , wherein the step of inserting the nucleic acid sequence of interest is performed by deletion in the receiving vector of the nucleotide sequence encoding the first poison protein and by its replacement with the nucleic acid sequence of interest.

9. The method according to claim 1 , wherein the cell is an E. Coli cell.

10. The method of claim 5 , wherein the vectors incubation is made in presence of a recombination protein.

11. The method of claim 10 , wherein the recombination protein is a recombinase.

12. The method of claim 1 , wherein the cell carries the nucleotide encoding the second protein poison in its chromosome.

Assignees

• Szpirer Cédric
• Milinkovitch Michel C
• Gabant Philippe
• Univ Bruxelles

Inventors

• Szpirer Cédric
• Milinkovitch Michel C
• Gabant Philippe

Classifications

• C12N15/70

  Vectors or expression systems specially adapted for E. coli · CPC title

• C12N15/65

  using markers (enzymes used as markers C12N15/52) · CPC title

• C12N15/66

  General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease · CPC title

• C12N15/63 Primary

  Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title

• C12N15/10

  Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34) · CPC title